⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL360443 | 0.92 | — | — | |
| SCHEMBL9469528 | 0.90 | — | — | |
| SCHEMBL29264397 | 0.84 | — | — | |
| SCHEMBL736908 | 0.84 | L3MBTL3 (0.32) | — | |
| SCHEMBL738040 | 0.83 | — | — | |
| SCHEMBL206897 | 0.82 | CYP2D6 (0.33) | — | |
| SCHEMBL4159670 | 0.82 | CYP2D6 (0.33) | — | |
| SCHEMBL735435 | 0.82 | L3MBTL3 (0.31) | — | |
| SCHEMBL737602 | 0.82 | L3MBTL3 (0.31) | — | |
| SCHEMBL739062 | 0.82 | L3MBTL3 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1293 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12012404-B2 | Pyrimidoheterocyclic compounds and application thereof | D3 BIO (WUXI) CO., LTD. (CN) | 2024-06-18 | — | — | US | claimed |
| US-20240174692-A1 | PYRIMIDINE AROMATIC RING COMPOUNDS | MEDSHINE DISCOVERY INC. (CN) | 2024-05-30 | — | — | US | claimed |
| EP-4373827-A1 | KRAS G12D INHIBITORS AND USES THEREOF | Suzhou Zanrong Pharma Limited (CN) | 2024-05-29 | — | — | EP | claimed |
| US-20240140957-A1 | BRIDGED COMPOUNDS AS KRAS G12D INHIBITOR AND DEGRADER AND THE USE THEREOF | BEONE MEDICINES I GMBH (CH) | 2024-05-02 | — | — | US | claimed |
| CN-117917416-A | KRAS G12D degradation agent and preparation method and application thereof | 上海领泰生物医药科技有限公司 | 2024-04-23 | — | — | CN | claimed |
| CN-114615981-B | KRAS G12D inhibitors | 米拉蒂治疗股份有限公司 | 2024-04-12 | — | — | CN | claimed |
| US-20240116934-A1 | PYRIMIDOHETEROCYCLIC COMPOUNDS AND APPLICATION THEREOF | D3 BIO (WUXI) CO., LTD. (CN) | 2024-04-11 | — | — | US | claimed |
| EP-4349828-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Shanghai Yingli Pharmaceutical Co. Ltd. (CN) | 2024-04-10 | — | — | EP | claimed |
| US-20240092803-A1 | BRIDGED COMPOUNDS AS KRAS G12D INHIBITOR AND DEGRADER AND THE USE THEREOF | BEONE MEDICINES I GMBH (CH) | 2024-03-21 | — | — | US | claimed |
| CN-117645627-A | Heterocyclic compound and medical application thereof | 正大天晴药业集团股份有限公司 | 2024-03-05 | — | — | CN | claimed |
| CN-115260158-A | Compound of targeted protein regulator and application thereof | 上海医药集团股份有限公司 | 2022-11-01 | — | — | CN | claimed |
| WO-2022199587-A1 | PYRIMIDINE HETEROCYCLIC COMPOUND AND APPLICATION THEREOF | 南京明德新药研发有限公司 | 2022-09-29 | — | — | WO | claimed |
| WO-2022148421-A1 | BRIDGED COMPOUNDS AS KRAS G12D INHIBITOR AND DEGRADER AND THE USE THEREOF | BEIGENE, LTD. (KY) | 2022-07-14 | — | — | WO | claimed |
| WO-2022148422-A1 | BRIDGED COMPOUNDS AS KRAS G12D INHIBITOR AND DEGRADER AND THE USE THEREOF | BEIGENE, LTD. (KY) | 2022-07-14 | — | — | WO | claimed |
| CN-114615981-A | KRAS G12D inhibitors | 米拉蒂治疗股份有限公司 | 2022-06-10 | — | — | CN | claimed |
| CN-113321654-B | Fused pyridones as kinase inhibitors | 上海济煜医药科技有限公司 | 2022-05-03 | — | — | CN | claimed |
| WO-2021259331-A1 | EIGHT-MEMBERED N-CONTAINING HETEROCYCLIC COMPOUND | 南京明德新药研发有限公司 | 2021-12-30 | — | — | WO | claimed |
| CN-113321654-A | Fused pyridones as kinase inhibitors | 上海济煜医药科技有限公司 | 2021-08-31 | — | — | CN | claimed |
| US-20100093767-A1 | Mitotic Kinase Inhibitors | TAKEDA SAN DIEGO, INC. (US) | 2010-04-15 | — | — | US | claimed |
| WO-2006060737-A2 | MITOTIC KINESIN INHIBITORS | TAKEDA SAN DIEGO, INC. (US) | 2006-06-08 | — | — | WO | claimed |